 | Up a level |
Journal Article
Krug, U., Berdel, W. E., Gale, R. P., Haferlach, C., Schnittger, S., Mueller-Tidow, C., Braess, J., Spiekermann, K., Staib, P., Beelen, D., Serve, H., Schliemann, C., Stelljes, M., Balleisen, L., Maschmeyer, G., Grueneisen, A., Eimermacher, H., Giagounidis, A., Rasche, H., Hehlmann, R., Lengfelder, E., Thiel, E., Reichle, A., Aul, C., Ludwig, W-D, Kern, W., Haferlach, T., Koepcke, W., Goerlich, D., Sauerland, M. C., Heinecke, A., Woermann, B. J., Hiddemann, W. and Buechner, T. (2016). Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia. Leukemia, 30 (6). S. 1230 - 1237. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551
Pohlen, M., Braess, J., Thudium, J., Schmid, C., Kochanek, M., Kreuzer, K. -A, Goerlich, D., Gerth, U., Rhode, C., Mueller-Tidow, C., Stelljes, M., Buechner, T., Schlimok, G., Hallek, M., Waltenberger, J., Hiddemann, W., Berdel, W. E., Heilmeier, B. and Krug, U. (2016). Patients with acute myeloid leukemia admitted to intensive care units: Scores predicting outcome and post-ICU survival. Oncol. Res. Treat., 39. S. 51 - 52. BASEL: KARGER. ISSN 2296-5262
Schulze, A. B., Evers, G., Goerlich, D., Mohr, M., Marra, A., Hillejan, L., Rehkaemper, J., Heitkoetter, B. and Schmidt, L. H. (2020). Tumor infiltrating T cells influence prognosis in stage I-III NSCLC patients. Oncol. Res. Treat., 43 (SUPPL 4). S. 138 - 139. BASEL: KARGER. ISSN 2296-5262
Schulze, A. B., Schmidt, L. H., Heitkoetter, B., Huss, S., Mohr, M., Marra, A., Hillejan, L., Goerlich, D., Barth, P. J., Rehkaemper, J. and Evers, G. (2020). CD34(+) and SMA(+) cancer-associated fibroblasts influence prognosis in stage I-III NSCLC patients. Oncol. Res. Treat., 43 (SUPPL 4). S. 144 - 145. BASEL: KARGER. ISSN 2296-5262